A Study of Stereotactic Body Radiotherapy (SBRT) and Pluvicto (177Lu-PSMA-617) in People With Prostate Cancer

Full Title

STARLiT: STereotActic body Radiotherapy and 177Lutetium PSMA in Locally advanced prostate cancer: A Phase I/II Trial

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Daniel Gorovets’ office at 212-639-3983.

Protocol
25-322
Phase
Phase I/II (phases 1 and 2 combined)
Disease Status
Newly Diagnosed & Relapsed/Refractory
Investigator
Daniel Gorovets
Co-Investigators
Brandon Imber
Michael J. Morris
Heiko Schöder
Diseases
Genitourinary Cancer › Prostate Cancer
Prostate Cancer › Localized Disease
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT06574880
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description